Brief: Sprint Bioscience Q2 Operating Result Swings To Loss Of SEK 9.7 Mln
Aug 15 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q2 REVENUE SEK 2.9 MILLION VERSUS SEK 11.5 MILLION YEAR
AGO
* Q2 OPERATING LOSS SEK 9.7 MILLION VERSUS PROFIT SEK 1.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrb8xPRy
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program